<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We assessed the effect of <z:chebi fb="0" ids="52683">1,3-butanediol</z:chebi> on cerebral energy metabolism and <z:hpo ids='HP_0000969'>edema</z:hpo> after inducing multifocal brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> in 108 rats by the intracarotid injection of 50-microns carbonized microspheres </plain></SENT>
<SENT sid="1" pm="."><plain>An <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> dimer that induces systemic <z:hpo ids='HP_0001946'>ketosis</z:hpo>, 25 mmol/kg i.p. <z:chebi fb="0" ids="52684">butanediol</z:chebi> was injected every 3 hours to produce a sustained increase in the plasma level of beta-hydroxybutyrate </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment significantly attenuated <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced metabolic changes by increasing the concentrations of phosphocreatine, <z:chebi fb="3" ids="15422">adenosine triphosphate</z:chebi>, and <z:chebi fb="15" ids="28087">glycogen</z:chebi> and by reducing the concentrations of <z:chebi fb="1" ids="15361">pyruvate</z:chebi> and <z:chebi fb="4" ids="24996">lactate</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="4" ids="24996">Lactate</z:chebi> concentration 2, 6, and 12 hours after embolization decreased by 13%, 44%, and 46%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Brain water content increased from 78.63% in six unembolized rats to 80.93% in 12 saline-treated and 79.57% in seven <z:chebi fb="0" ids="52684">butanediol</z:chebi>-treated rats 12 hours after embolization </plain></SENT>
<SENT sid="5" pm="."><plain>(p less than 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The decrease in water content was associated with significant decreases in the concentrations of <z:chebi fb="199" ids="26708">sodium</z:chebi> and <z:chebi fb="76" ids="17996">chloride</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>The antiedema effect of <z:chebi fb="0" ids="52684">butanediol</z:chebi> could not be explained by an osmotic mechanism since equimolar doses of <z:chebi fb="20" ids="16199">urea</z:chebi> or <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> were ineffective </plain></SENT>
<SENT sid="8" pm="."><plain>Our results support the hypothesis that the beneficial effect of <z:chebi fb="0" ids="52684">butanediol</z:chebi> is mediated through cerebral utilization of <z:chebi fb="3" ids="17087">ketone</z:chebi> bodies arising from <z:chebi fb="0" ids="52684">butanediol</z:chebi> metabolism, reducing the rate of glycolysis and the deleterious accumulation of <z:chebi fb="22" ids="28358">lactic acid</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>